Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Teodora Radonic"'
Autor:
Franziska Böttger, Teodora Radonic, Idris Bahce, Kim Monkhorst, Sander R. Piersma, Thang V. Pham, Anne‐Marie C. Dingemans, Lisa M. Hillen, Mariacarmela Santarpia, Elisa Giovannetti, Egbert F. Smit, Sjaak A. Burgers, Connie R. Jimenez
Publikováno v:
Molecular Oncology, Vol 18, Iss 6, Pp 1417-1436 (2024)
The majority of patients with resected stage II‐IIIA non‐small cell lung cancer (NSCLC) are treated with platinum‐based adjuvant chemotherapy (ACT) in a one‐size‐fits‐all approach. However, a significant number of patients do not derive c
Externí odkaz:
https://doaj.org/article/59cc7532a44a481fb7f9c9573d143ffd
Autor:
Tanja D de Gruijl, Teodora Radonic, Marc C Huisman, Idris Bahce, Johanna E E Pouw, Sayed M S Hashemi, Jessica E Wijngaarden, Maarten Slebe, Daniela E Oprea-Lager, Gerben J C Zwezerijnen, Danielle Vugts, Ezgi B Ulas, Suresh Senan, C Willemien Menke-van der Houven van Oordt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background In patients with locally advanced unresectable non-small cell lung cancer (NSCLC), durvalumab, an anti-programmed cell death ligand-1 (PD-L1) antibody, has shown improved overall survival when used as consolidation therapy following concur
Externí odkaz:
https://doaj.org/article/4b3a18abdb6f4a34986c4c57af3d9db7
Autor:
Benoit Lechartier, Athénaïs Boucly, Sabina Solinas, Deepa Gopalan, Peter Dorfmüller, Teodora Radonic, Olivier Sitbon, David Montani
Publikováno v:
European Respiratory Review, Vol 33, Iss 171 (2024)
Pulmonary veno-occlusive disease (PVOD), also known as “pulmonary arterial hypertension (PAH) with overt features of venous/capillary involvement”, is a rare cause of PAH characterised by substantial small pulmonary vein and capillary involvement
Externí odkaz:
https://doaj.org/article/26126b5e7c2d47f48fd0ba3420c91a76
Autor:
Illaa Smesseim, Robert A. vanBoerdonk, Chris Dickhoff, David J. Heineman, Max R. Dahele, Teodora Radonic, Idris Bahce, Simone P. Rauh, Emile F. I. Comans, Hans (J. M. A.) Daniels
Publikováno v:
Thoracic Cancer, Vol 14, Iss 9, Pp 840-847 (2023)
Abstract Introduction Pre‐invasive squamous lesions of the central airways can progress into invasive lung cancers. Identifying these high‐risk patients could enable detection of invasive lung cancers at an early stage. In this study, we investig
Externí odkaz:
https://doaj.org/article/e71e7ab1bfc648928cada2fe02e71578
Autor:
Ezgi B. Ulas, BSc, Sayed M.S. Hashemi, MD, Ilias Houda, MD, Adem Kaynak, MSc, Joris D. Veltman, MD, PhD, Marieke F. Fransen, PhD, Teodora Radonic, MD, PhD, Idris Bahce, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 9, Pp 100532- (2023)
Introduction: In advanced-stage NSCLC, tumor proportion score (TPS) is typically used to predict the efficacy of immune checkpoint inhibitors (ICIs). Nevertheless, in other cancer types, the combined positive score (CPS), which covers programmed deat
Externí odkaz:
https://doaj.org/article/e19f82a0ac474b54adcefd75bbe9d1ac
Autor:
Chris Dickhoff, Suresh Senan, Famke L. Schneiders, Joris Veltman, Sayed Hashemi, Johannes M. A. Daniels, Marieke Fransen, David J. Heineman, Teodora Radonic, Peter M. van de Ven, Imke H. Bartelink, Lilian J. Meijboom, Juan J. Garcia-Vallejo, Daniela E. Oprea-Lager, Tanja D. de Gruijl, Idris Bahce
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background The likelihood of a tumor recurrence in patients with T3-4N0–1 non-small cell lung cancer following multimodality treatment remains substantial, mainly due distant metastases. As pathological complete responses (pCR) in resected
Externí odkaz:
https://doaj.org/article/b810006f73e5465ca6860f5c7acd4a6c
Autor:
Tanja de Gruijl, Teodora Radonic, Chris Dickhoff, Marieke Fransen, Famke Schneiders, Vinitha Kandiah, Idris Bahce
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/fc91662ef29942c99972f61ea8a47223
Publikováno v:
Cancers, Vol 14, Iss 15, p 3772 (2022)
Small cell lung cancer (SCLC) is a high-grade neuroendocrine malignancy with an aggressive behavior and dismal prognosis. 5-year overall survival remains a disappointing 7%. Genomically, SCLCs are homogeneous compared to non-small cell lung cancers a
Externí odkaz:
https://doaj.org/article/a320476b17b7486fb3a56a36b72b5075
Autor:
Ellen M. B. P. Reuling, Dwayne D. Naves, Pim C. Kortman, Mark A. M. Broeckaert, Peter W. Plaisier, Chris Dickhoff, Johannes M. A. Daniels, Teodora Radonic
Publikováno v:
Cancers, Vol 14, Iss 13, p 3234 (2022)
Background: Curatively treated bronchial carcinoid tumors have a relatively low metastatic potential. Gradation into typical (TC) and atypical carcinoid (AC) is limited in terms of prognostic value, resulting in yearly follow-up of all patients. We e
Externí odkaz:
https://doaj.org/article/0dce3de4ef33457ab20c45481688db96
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
Inflammatory myofibroblastic tumours (IMT) are a rare cause of endobronchial masses in adults. Surgery has been the mainstay of treatment of endobronchial IMTs, based on the potential for recurrence. Interventional pulmonology has emerged as a minima
Externí odkaz:
https://doaj.org/article/4e258299049a4d389e43ad67ce587e37